Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

1Biomarkers and Clonal Dynamics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain.

Copyright held by the owner/author(s).

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

1Ontario Institute for Cancer Research, Toronto, Canada. 2Department of Human Genetics, University of California, Los Angeles, Los Angeles, California. 3Jonsson ...

1State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of ...

Osteosarcoma (OS) is the most common malignant bone cancer. Thirty to forty percent of all patients with OS develop tumor recurrence, almost exclusively in the form of lung metastasis, which is ...

1Department of Urology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, China. 2Department of Urology, Shanghai Changzheng Hospital, Naval Medical ...

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese ...

Gretchen M. Alicea; Payal Patel; Marie E. Portuallo; Mitchell E. Fane; Meihan Wei; Yash Chhabra; Agrani Dixit; Alexis E. Carey; Vania Wang; Murilo R. Rocha; Reeti ...

David Fandrei; Sabine Seiffert; Michael Rade; Susanne Rieprecht; Nico Gagelmann; Patrick Born; Thomas Wiemers; Heike Weidner; Markus Kreuz; Tamara Schassberger ...